DIJON, France, April 11, 2025 /PRNewswire/ — PROTEOR, a global leader in prosthetics and orthotics (O&P), announced today the expansion of its Digital solutions and a first-in-the-industry innovation: The production of non-vase mode definitive sockets via 3D Printing fabrication.
This new definitive socket utilizes a proprietary material, KyronMAX®, sourced from an exclusive partnership with Mitsubishi Chemical Group; this material, which offers increased tensile strength and toughness qualities, enables 3D Printed PROTEOR sockets to exceed ISO 10328 standards when utilizing the PROTEOR ICARUS 3D Printer. Moving beyond traditional fabrication processes, the 3D printing method used by PROTEOR ensures clinical efficiencies, consistent quality & durability, and a tailored fit for each individual. By expanding its offering to include a non-vase mode design, PROTEOR bridges the gap between cutting-edge technology and real-world needs.
“We are committed to providing our customers with the most advanced 3D printing technologies available today – including the highest-quality filaments available,” said Mike Gorski, General Manager, Proteor Printing Solutions. “PROTEOR is delivering what the industry has been waiting for – in-house 3D Printed Definitive sockets with a streamlined workflow process. In this industry, I have learned a lot from our customers on how this process needs to be simplified. After the acquisition of Filament Innovations, I brought this knowledge to PROTEOR and the teams created a streamlined workflow process around definitive sockets. Utilizing the ORTEN software, an ICARUS 3D Printer, and KyronMAX® material, definitive prosthetic sockets can now be 3D printed in-house within a few hours. This is the technological revolution the industry has been waiting for. I am thrilled to announce there is no more wait, this technology is ready today and has been scientifically validated.”
This breakthrough underscores PROTEOR’s dedication to pushing boundaries and setting new benchmarks in the O&P field. With this non-vase mode design, the company not only leads in innovation but also charts a course for a future where advanced technology is seamlessly integrated into daily clinical practice.
To help support this Digital future, the company is preparing to launch its comprehensive PROTEOR Digital Suite in May—an expansive digital solutions platform that includes innovations in scanning, software, and printing services. This integrated system is designed to streamline workflows and enhance both patient outcomes and clinical efficiency.
For media inquiries, please contact:
Eric Ferris
Vice President, Global Marketing & Product Management
PROTEOR
eric.ferris@proteor.com / +1.855.450.7500
http://us.proteor.com
Alexandra Houiste
Manager, Corporate Communications
PROTEOR
alexandra.houiste@proteor.com / +33 3 80 78 42 42
SOURCE PROTEOR
"The Hidden Divide" Exposes Gaps in Healthcare Provider Education and Care Delivery MIAMI, April 21,…
NAGOYA, Japan, April 21, 2025 /PRNewswire/ -- Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced…
Transaction Further Strengthens Company's Position in High-Growth Foot and Ankle Segment WARSAW, Ind., April 21, 2025…
COPENHAGEN, Denmark, April 21, 2025 /PRNewswire/ -- CathVision, a leader in advanced cardiac electrophysiology (EP)…
NEW YORK, April 21, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a…
CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that…